The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity.
Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...
Sadler's Wells East has officially opened in what was described as a "gamechanger" for dance in London. Located in the Queen ...
Research suggests arts and cultural engagement can be used to help treat the symptoms of a number of conditions, including ...
Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...
Philippe Sands’ comments, accusing the Conservatives of playing into an antisemitic trope, were dismissed as an “absurd smear ...
With its flattering rhetoric, leniency in responding to US trade threats and alignment with Washington this week at a summit ...
The Associated Press on MSN8d
Allies to discuss arms for Ukraine amid doubts about U.S. intentionsThe main international forum for drumming up weapons and ammunition for Ukraine will for the first time meet under the ...
The Healthy on MSN3d
This Is the Happiest Time of Day, Finds a New StudyA study of almost 50,000 individuals revealed there's a window of the day—and the week—worth safeguarding and savoring.
The first of two vessels carrying 1,000 tons of a Chinese-made chemical that could be a key component in fuel for Iran’s ...
NextGen Healthcare, a leading provider of innovative healthcare technology, is rounding out its c-suite with the addition of technology veteran Sanjeev Kumar, Ph.D., as Chief Data and Analytics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback